These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy. Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094 [TBL] [Abstract][Full Text] [Related]
12. Long-term progression-free survival in metastatic uveal melanoma after chemoimmunotherapy and consolidation thermoablation. Al-Jamal RT; Eskelin S; Pyrhönen S; Kivelä T Acta Oncol; 2009; 48(3):476-9. PubMed ID: 19031163 [No Abstract] [Full Text] [Related]
13. [Skin cancer melanoma]. Ishihara K Gan To Kagaku Ryoho; 1999 Jun; 26 Suppl 1():173-84. PubMed ID: 10410672 [TBL] [Abstract][Full Text] [Related]
14. Cytokine-based therapy and biochemotherapy for advanced melanoma. Atkins MB Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2353s-2358s. PubMed ID: 16609058 [TBL] [Abstract][Full Text] [Related]
15. [New therapeutic approachs in melanoma]. Mortier L; Marchetti P; Gordower L; Charbonnier-Hatzfeld AS; Toungouz M; Velu T Rev Med Brux; 2004 Jun; 25(3):153-9. PubMed ID: 15291447 [TBL] [Abstract][Full Text] [Related]
16. [Treatment for melanoma]. Takada M Gan To Kagaku Ryoho; 2008 Apr; 35(4):588-90. PubMed ID: 18468001 [No Abstract] [Full Text] [Related]
17. Isolated limb infusion for melanoma: a simple but effective alternative to isolated limb perfusion. Thompson JF; Kam PC J Surg Oncol; 2004 Oct; 88(1):1-3. PubMed ID: 15384062 [No Abstract] [Full Text] [Related]